T1	Participants 13 25	Wilms' tumor
T2	Participants 147 164	low-risk patients
T3	Participants 198 228	those at high risk for relapse
T4	Participants 239 254	patients (1439)
T5	Participants 1307 1324	low-risk patients
T6	Participants 1049 1067	high-risk patients
